ANNEXSupplementary provisions
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Rafoxanide Rafoxanide Bovine 30 μg/kg 30 μg/kg 10 μg/kg 40 μg/kg Muscle Fat Liver Kidney NO ENTRY Antiparasitic agents/Agents against endoparasites’ Ovine 100 μg/kg 250 μg/kg 150 μg/kg 150 μg/kg Muscle Fat Liver Kidney Bovine, ovine 10 μg/kg Milk Provisional MRL shall expire on 31 December 2017